Hyperthermia-enhanced effectiveness of Mitoxantrone in an experimental rat tumour

International Journal of Hyperthermia

Volumn 12, Issue 2, 1996, Pages 241-254

  Schopman, E M ^a   Van Bree, C ^a   Bakker, P J M ^a   Kipp, J B A ^a   Barendsen, G W ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MITOXANTRONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLONOGENESIS; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG TISSUE LEVEL; HYPERTHERMIC THERAPY; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; RAT; RHABDOMYOSARCOMA; TIME; TUMOR VOLUME;

EID: 0029978320     PISSN: 02656736     EISSN: None     Source Type: Journal    
DOI: 10.3109/02656739609022512     Document Type: Article

References (25)

1. BALLARD, B. E., 1974, Pharmacokinetics and hyperthermia. Journal of Pharmacological Sciences, 63, 1345-1358.
2. BARENDSEN, G. W., and BROERSE, J. J., 1969, Experimental radiotherapy of a rat rhabdomyosarcoma with 15 MeV neutrons and 300kV X-rays: I. Effects of single exposure. European Journal of Cancer, 5, 373-391.
3. BATRA, V. K., MORRISON, J. A., WOODWARD, D. L., SIVERD, N. S., and YACOBI. A., 1986, Pharmacokinetics of mitoxantrone in man and laboratory animals. Drug Metabolism Reviews, 17, 311-329.
4. BULL, J. M., 1984, An update on the anti-cancer effects of a combination of chemotherapy and hyperthermia. Cancer Research (supplement), 44, 4853s-4856s.
5. DAHL, O., and MELLA, O., 1987, Effect of timing and sequence of hyperthermia and cyclophos-phamide on a neurogenic rat tumour (BTA 4) in vivo. Cancer. 52, 983-987.
6. DAHL, O., 1988, Interaction of hyperthermia and chemotherapy. Recent Results in Cancer Reseaerch, 107, 157-169.
7. EMGELHARDT, R., 1987, Hyperthermia and drugs. Recent Results in Cancer Research, 104, 136-203.
8. FAULDS, D., BALFOUR, J. A., CHRISP, P., and LANGTRY, H. D., 1991, Mitoxantrone. A review of its pharmacokinetic properties, and therapeutic potential in the chemotherapy of cancer. Drugs, 41, 400-449.
9. FUJIMOTO, S., and OGAWA, M., 1980, Antitumor activity of mitoxantrone against murine experimental tumours: Comparative analysis against various antitumour antibiotics. Cancer Chemotherapy Pharmacology, 8, 157-162.
10. HAHN, G. M., 1978. Interactions of drugs and hyperthermia in vitro and in vivo. In: Streffer, C., Van Beuningen, D., Dietzel, F., Roettinger, E., Robinson, J. E., Scherer, E., Seeber, S., and Trott, K. B. (eds): Cancer therapy by hyperthermia and radiation. Proceedings of the 2nd International Symposium, Essen Urban and Schwarzenberg, Baltimore, 72-79 pp.
11. HAHN, G. M., 1982, Hyperthermia and Cancer (New York and London: Plenum Press).
12. HERMAN, T. S., 1983, Effect of temperature on the cytotoxicity of vindesine. amsasine and mitoxantrone. Cancer Treatments Reports, 67, 1019-1022.
13. JUVEKAR, A., CHITNIS, M., ADWANKAR, M., and ADVANI, S., 1986, Effect of mitoxantrone on human chronic myeloid leukemia cells in vitro, combined with hyperthermia. Neoplasma, 33 (4), 477-482.
14. NOOTER, K., DE VRIES, A. J., MARTENS, A. C. M., and HAGENBEEK, A., 1991, The bone marrow as a pharmacological sanctuary for anthracycline drug in a rat acute leukemia model. Annals on Haematology, 62 (1), 24-26.
15. NOWAK, K., PECKHAM, M. J., and STEEL, G. G., 1978, Variation in response of colorectal carcinoma to chemotherapy. British Journal of Cancer, 37, 576-584.
16. OHNOSHI, T., OHNUMA, T., BERCNEK, J. T., and HOLLAND, J. F., 1985, Combined cytotoxicity effect of hyperthermia and anthracycline antibodies on human tumour cells. Journal of the National Cancer Institute, 71, 275-281.
17. PENG, Y. M., DAVIS, T. P., and ALBERTS, D. S., 1982, High performance liquid chromatography of a new anti-cancer drug, ADCA: physiochemical properties and pharmacokinetics. Life Science, 271, 364-369.
18. REINHOLD, H. S., 1965, A cell dispersion technique for use in quantitative transplantation studies with solid tumors. European Journal of Cancer, 1, 67-71.
19. RICE, G. C., and HAHN, G. M., 1987, Modulation of adriamycin transport by hyperthermia as measured by fluorescence-activated cell sorting. Cancer Chemotherapy and Pharmacology, 20, 183-187.
20. ROBOZ, J., PACIUCCI, P. M., SILIDES, D., and GREAVES, J., 1984, Detection and quantification of mitoxantrone in human organs. A case report. Cancer Chemotherapy and Pharmacology, 13, 67-68.
21. SUNDBERG-ENGBERG, B., TIDEFELT, U., GRUBER, A., and PAUL, C., 1993, Intracellular concentrations of mitoxantrone in leukemic cells in vitro vs in vivo. Leukemia Research, 17 (4), 347-352.
22. TRACEY, K. J., 1986, Shock and tissue injury induced by recombinant human cachectin. Science, 234, 471-474.
23. WALLACE, R. E., MURDOCK, K. C., ANGIER, R. B., and DURR, F. E., 1979, Activity of a novel anthracenedione, 1,4-dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)-amino]ethyl]amino]-9,10- anthracenedione dihydrochloride, against experimental tumors in mice. Cancer Research, 39, 1570-1574.
24. WANG, B. S., LUMANGLAS, A. L., RUSZAKLA-MALLON, V., WALLACE, R. E., and DURR, F. E., 1984, Effect of hyperthermia on the sensitivity of human colon carcinoma cells to mitoxantrone. Proceedings of the American Association for Cancer Research, 25, 341.
25. WIEDEMANN, G., MELLA, O., ROSZINSKI, S., WIESS, C., and WAGNER, TH., 1992, Hyperthermia enhances mitoxantrone cytotoxicity on human breast carcinoma and sarcoma xenografts in nude mice. International Journal for Radiation, Oncology, Biology and Physics, 24, 669-673.